Transcend Capital Advisors LLC Buys 54 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Transcend Capital Advisors LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,187 shares of the company’s stock after purchasing an additional 54 shares during the period. Transcend Capital Advisors LLC’s holdings in HCA Healthcare were worth $321,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Kinetic Partners Management LP bought a new position in shares of HCA Healthcare in the 3rd quarter valued at $50,524,000. EP Wealth Advisors LLC grew its stake in shares of HCA Healthcare by 501.8% in the third quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company’s stock worth $51,401,000 after purchasing an additional 174,240 shares during the last quarter. Canada Pension Plan Investment Board raised its position in HCA Healthcare by 51.6% during the 3rd quarter. Canada Pension Plan Investment Board now owns 355,730 shares of the company’s stock worth $87,502,000 after purchasing an additional 121,100 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its position in shares of HCA Healthcare by 83.4% during the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 254,408 shares of the company’s stock worth $62,579,000 after acquiring an additional 115,720 shares during the last quarter. Finally, Avidity Partners Management LP acquired a new stake in HCA Healthcare during the 3rd quarter valued at approximately $28,239,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $311.42 on Tuesday. The firm’s fifty day moving average price is $323.67 and its 200-day moving average price is $295.56. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $335.83. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The stock has a market cap of $82.36 billion, a P/E ratio of 15.52, a price-to-earnings-growth ratio of 1.48 and a beta of 1.65.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same period last year, the business earned $4.93 earnings per share. The business’s quarterly revenue was up 11.2% on a year-over-year basis. On average, equities research analysts expect that HCA Healthcare, Inc. will post 20.58 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.85%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare declared that its board has approved a share buyback plan on Tuesday, January 30th that permits the company to repurchase $6.00 billion in shares. This repurchase authorization permits the company to buy up to 7.4% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

HCA has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Oppenheimer raised their price objective on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research note on Monday. Royal Bank of Canada increased their price objective on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday. Truist Financial boosted their price objective on HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Finally, Wells Fargo & Company increased their target price on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Four analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $313.88.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the completion of the sale, the senior vice president now owns 2,452 shares of the company’s stock, valued at approximately $789,470.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Michael S. Cuffe sold 3,200 shares of the firm’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total value of $981,728.00. Following the completion of the sale, the executive vice president now owns 24,929 shares of the company’s stock, valued at $7,647,967.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Chad J. Wasserman sold 344 shares of HCA Healthcare stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at approximately $789,470.44. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,840 shares of company stock worth $4,588,869. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.